These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 11887165)
21. Glucose fluxes and oxidation after an oral glucose load in patients with non-insulin-dependent diabetes mellitus of variable severity. Féry F; Melot C; Balasse EO Metabolism; 1993 Apr; 42(4):522-30. PubMed ID: 8487677 [TBL] [Abstract][Full Text] [Related]
22. Comparative continuous-indirect-calorimetry study of two carbohydrates with different glycemic indices. Ritz P; Krempf M; Cloarec D; Champ M; Charbonnel B Am J Clin Nutr; 1991 Nov; 54(5):855-9. PubMed ID: 1951156 [TBL] [Abstract][Full Text] [Related]
23. Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy. Reiser M; Salzberger B; Stiepel A; Hoetelmans R; Diehl V; Fätkenheuer G Eur J Med Res; 1999 Feb; 4(2):54-8. PubMed ID: 10066640 [TBL] [Abstract][Full Text] [Related]
24. Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine. Martínez E; Conget I; Lozano L; Casamitjana R; Gatell JM AIDS; 1999 May; 13(7):805-10. PubMed ID: 10357379 [TBL] [Abstract][Full Text] [Related]
26. Effect of added fat on plasma glucose and insulin response to ingested potato in individuals with NIDDM. Gannon MC; Ercan N; Westphal SA; Nuttall FQ Diabetes Care; 1993 Jun; 16(6):874-80. PubMed ID: 8325201 [TBL] [Abstract][Full Text] [Related]
27. Abnormalities in plasma fatty acid composition in human immunodeficiency virus-infected children treated with protease inhibitors. Aldámiz-Echevarría L; Pocheville I; Sanjurjo P; Elorz J; Prieto JA; Rodríguez-Soriano J Acta Paediatr; 2005 Jun; 94(6):672-7. PubMed ID: 16188767 [TBL] [Abstract][Full Text] [Related]
28. Remarkable metabolic availability of oral glucose during long-duration exercise in humans. Pallikarakis N; Jandrain B; Pirnay F; Mosora F; Lacroix M; Luyckx AS; Lefebvre PJ J Appl Physiol (1985); 1986 Mar; 60(3):1035-42. PubMed ID: 3514570 [TBL] [Abstract][Full Text] [Related]
29. Comparison of carbohydrate utilization in man using indirect calorimetry and mass spectrometry after an oral load of 100 g naturally-labelled [13C]glucose. Ebiner JR; Acheson KJ; Doerner A; Maeder E; Arnaud MJ; Jéquier E; Felber JP Br J Nutr; 1979 May; 41(3):419-29. PubMed ID: 465433 [TBL] [Abstract][Full Text] [Related]
30. Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity. Suh KI; Murata C; Song YM; Joyce M; Gumbiner B; Ditzler TM; Henry RR J Clin Endocrinol Metab; 1993 Aug; 77(2):464-70. PubMed ID: 8345053 [TBL] [Abstract][Full Text] [Related]
32. Diverse pattern of protease inhibitor resistance mutations in HIV-1 infected patients failing nelfinavir. Svedhem V; Lindkvist A; Bergroth T; Knut L; Sönnerborg A J Med Virol; 2005 Aug; 76(4):447-51. PubMed ID: 15977242 [TBL] [Abstract][Full Text] [Related]
33. Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors. Beatty G; Khalili M; Abbasi F; Chu J; Reaven GM; Rosen A; Schmidt JM; Stansell J; Koch J J Acquir Immune Defic Syndr; 2003 May; 33(1):34-40. PubMed ID: 12792353 [TBL] [Abstract][Full Text] [Related]
34. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. Behrens G; Dejam A; Schmidt H; Balks HJ; Brabant G; Körner T; Stoll M; Schmidt RE AIDS; 1999 Jul; 13(10):F63-70. PubMed ID: 10416516 [TBL] [Abstract][Full Text] [Related]
35. Metabolic response to a 13C-glucose load in human immunodeficiency virus in patients before and after antiprotease therapy. van der Valk M; Heijligenberg R; Sauerwein HP Metabolism; 2003 Apr; 52(4):520; author reply 520. PubMed ID: 12701069 [No Abstract] [Full Text] [Related]
36. Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. van der Valk M; Bisschop PH; Romijn JA; Ackermans MT; Lange JM; Endert E; Reiss P; Sauerwein HP AIDS; 2001 Nov; 15(16):2093-100. PubMed ID: 11684928 [TBL] [Abstract][Full Text] [Related]
37. HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study. Petit JM; Duong M; Duvillard L; Piroth L; Grappin M; Verges B; Chavanet P; Brun JM; Portier H Horm Metab Res; 2000 Sep; 32(9):367-72. PubMed ID: 11014386 [TBL] [Abstract][Full Text] [Related]
38. High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy. Goujard C; Legrand M; Panhard X; Diquet B; Duval X; Peytavin G; Vincent I; Katlama C; Leport C; Bonnet B; Salmon-Céron D; Mentré F; Taburet AM; Clin Pharmacokinet; 2005; 44(12):1267-78. PubMed ID: 16372824 [TBL] [Abstract][Full Text] [Related]
39. A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled study. Fisac C; Virgili N; Ferrer E; Barbera MJ; Fumero E; Vilarasau C; Podzamczer D J Clin Endocrinol Metab; 2003 Nov; 88(11):5186-92. PubMed ID: 14602748 [TBL] [Abstract][Full Text] [Related]
40. Metabolic fate of a large amount of 13C-glycerol ingested during prolonged exercise. Massicotte D; Scotto A; Péronnet F; M'Kaouar H; Milot M; Lavoie C Eur J Appl Physiol; 2006 Feb; 96(3):322-9. PubMed ID: 16369815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]